Abbelight Announces Successful Series B Investment led by AVANT BIO to Accelerate Imaging Innovation and Scale Adoption Across a Broader Customer Base January 8, 2026 Abbelight, a global leader and a pioneer in super-resolution microscopy end-to-end solutions, today announced a successful Series B financing round led by AVANT BIO, a growth equity firm focused on enabling technologies shaping tomorrow’s therapeutics. “With a decade of experience in the Life Science Research market, Abbelight has been transforming the way scientists see, quantify, [...]
I’ve been speaking to CEOs all year – this is what they really think December 24, 2025 After spending a year interviewing some of the UK’s top business leaders, a number of themes have emerged which paint a concerning picture of their confidence in this country’s future prospects – but there is also hope. In 25 episodes of City AM‘s Boardroom Uncovered podcast series in 2025, a large number of the CEOs [...]
StretchSense Raises $2.3M to Drive Global Expansion of XR Training Gloves December 19, 2025 Wearables technology firm StretchSense, which specialises in high-tech data capture gloves, has secured its latest external investment, a $2.3 million (£1.75m) round led by PXN Ventures and supported by Scottish Enterprise, as the company aims to drive the global expansion of its extended reality (XR) training glove that enables organisations to immerse staff in simulated [...]
PairSoft Announces Majority Growth Investment from TA December 17, 2025 PairSoft, a leading provider of procure-to-pay automation and payment solutions, today announced a majority investment from TA Associates (“TA”), a leading global private equity firm. The partnership will support PairSoft’s continued product enhancement, innovation and global expansion. As a result of the transaction, existing investor Turn/River Capital will fully exit its stake in the business. [...]
Gambit Cyber Raises $3.4M Seed Round Led by Expeditions, with Participation of Bitdefender Voyager Ventures, to Scale Agentic AI-Driven and Risk Centric Continuous Threat Exposure Management December 17, 2025 Gambit Cyber, an emerging leader in AI-native preemptive cybersecurity, today announced the successful close of its US$ 3.4 million seed funding round, led by Expeditions, the leading early-stage investor in European security, with participation of Bitdefender Voyager Ventures, the early-stage investment arm of global cybersecurity leader Bitdefender, backing startups in cybersecurity, automation, and data-driven technologies. [...]
SkillCorner Announces $60 Million Growth Investment from Silversmith Capital Partners December 17, 2025 Investment will accelerate global expansion of AI-powered sports analytics across soccer, basketball, and football
KKR and Premialab Announce A $220m Strategic Investment To Power Next Phase Of Global Growth December 16, 2025 Premialab, a global provider of data, analytics and risk management solutions for quantitative investing, today announces a significant $220m growth investment from funds and accounts managed by KKR, a leading global investment firm. Under the terms of the agreement, KKR will lead a significant growth investment alongside existing investor Balderton. Founded by Adrien Géliot and [...]
Lightspeed Closes Over $9B in New Funds Aimed at Backing Category Definers Worldwide December 15, 2025 Lightspeed Venture Partners raised capital across six vehicles, underscoring the firm’s bespoke fund architecture and deep AI investment track record
Marathon Asset Management Provides Junior Capital Financing to EXALTA Group December 15, 2025 Marathon Asset Management (“Marathon”), a leading global credit manager with more than $24 billion of assets under management, is pleased to announce the closing of a junior capital financing to EXALTA Group (“EXALTA” or the “Company”), a portfolio company of Montagu. Marathon led the financing that supported the formation of EXALTA through the strategic merger [...]
SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion December 15, 2025 SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values [...]